
CHGCF
Healthcare · Drug Manufacturers - General · $74.95B market cap
$45.55+1.24 (+2.8%)Nov 13, 9:30 AM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Oct 27, 2026 | After the close | 78.92 | 0.55 | -99.3% |
| Jul 24, 2026 | After the close | 74.57 | 0.44 | -99.4% |
| Apr 24, 2026 | After the close | 65.43 | 0.45 | -99.3% |
| Oct 24, 2025 | After the close | 73.28 | 0.46 | -99.4% |
| Jul 24, 2025 | After the close | 72.62 | 0.41 | -99.4% |
| Apr 24, 2025 | Before the open | 48.57 | 59.09 | +21.7% |
| Jan 30, 2025 | Before the open | 58.29 | 55.64 | -4.5% |
| Oct 25, 2024 | Before the open | 68.53 | 66.55 | -2.9% |
| Jul 25, 2024 | Before the open | 52.20 | 67.98 | +30.2% |
| Apr 24, 2024 | Before the open | 42.91 | 45.22 | +5.4% |
| Feb 1, 2024 | Before the open | 48.10 | 55.43 | +15.2% |
| Oct 24, 2023 | Before the open | 53.08 | 47.15 | -11.2% |
| Jul 27, 2023 | Before the open | 45.90 |
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. It offers oncology products, such as Alecensa, Avastin, FoundationOne, Herceptin, Kadcyla, Lunsumio, Perjeta, Phesgo, Polivy, and Tecentriq; Actemra for humanized anti-human IL-6 receptor monoclonal antibody; CellCept,…
| 50.57 |
| +10.2% |
| Apr 27, 2023 | Before the open | 44.80 | 44.68 | -0.3% |
| Feb 2, 2023 | Before the open | — | 62.29 | — |
| Oct 24, 2022 | Before the open | 45.00 | 41.21 | -8.4% |
| Jul 21, 2022 | Before the open | 44.00 | 44.00 | 0.0% |
| Apr 25, 2022 | Before the open | 36.00 | 80.14 | +122.6% |
| Feb 3, 2022 | Before the open | — | 60.12 | — |
| Oct 22, 2021 | Before the open | 38.60 | 52.32 | +35.5% |
| Jul 26, 2021 | Before the open | — | 43.02 | — |
| Apr 22, 2021 | Before the open | 34.20 | 28.84 | -15.7% |
| Feb 4, 2021 | Before the open | — | 31.82 | — |
| Oct 22, 2020 | Before the open | 31.00 | 36.58 | +18.0% |
| Jul 27, 2020 | Before the open | 31.33 | 30.89 | -1.4% |
| Apr 23, 2020 | Before the open | 30.27 | 31.37 | +3.6% |
| Jan 30, 2020 | Before the open | 24.83 | 24.45 | -1.5% |
| Oct 24, 2019 | Before the open | 20.80 | 29.31 | +40.9% |
| Jul 25, 2019 | Before the open | 17.73 | 20.84 | +17.5% |
| Apr 24, 2019 | Before the open | 18.57 | 21.34 | +14.9% |
| Jan 31, 2019 | Before the open | — | 13.49 | — |
| Oct 24, 2018 | Before the open | 13.93 | 13.20 | -5.2% |
| Jul 26, 2018 | Before the open | 10.93 | 12.67 | +15.9% |
| Apr 24, 2018 | Before the open | 15.77 | 17.00 | +7.8% |
| Feb 1, 2018 | Before the open | 11.09 | 9.46 | -14.7% |